We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $658M
1-Year Est. Return 39.64%
This Fund
S&P 500
This Quarter Est. Return
+13.7%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.15%
AUM
$412M
AUM Growth
+$47.2M
Cap. Flow
+$3.52M
Cap. Flow %
0.85%
Top 10 Hldgs %
36.89%
Holding
166
New
6
Increased
62
Reduced
64
Closed
2

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.51M
2
MMM icon
3M
MMM
+$1.27M
3
MRK icon
Merck
MRK
+$1.16M
4
BMY icon
Bristol-Myers Squibb
BMY
+$760K
5
CVS icon
CVS Health
CVS
+$577K

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Industrials 17.05%
3 Healthcare 16.18%
4 Consumer Staples 8.6%
5 Financials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USB icon
26
US Bancorp
USB
$100B
$3.96M 0.96%
84,944
+2
+0% +$85
IBM icon
27
IBM
IBM
$222B
$3.87M 0.94%
32,150
-428
-1% -$49.5K
PG icon
28
Procter & Gamble
PG
$345B
$3.8M 0.92%
27,339
-99
-0.4% -$13.8K
BAC icon
29
Bank of America
BAC
$440B
$3.76M 0.91%
123,932
+213
+0.2% +$5.71K
SCHX icon
30
Schwab US Large- Cap ETF
SCHX
$74.2B
$3.66M 0.89%
241,272
+1,422
+0.6% +$20.3K
HUBB icon
31
Hubbell
HUBB
$26.5B
$3.65M 0.89%
23,301
EMR icon
32
Emerson Electric
EMR
$89B
$3.52M 0.85%
43,771
+1,050
+2% +$78.1K
WBA
33
DELISTED
Walgreens Boots Alliance
WBA
$3.49M 0.85%
87,636
-4,071
-4% -$158K
SCHW
34
Charles Schwab
SCHW
$185B
$3.41M 0.83%
64,225
-140
-0.2% -$6.34K
WAT icon
35
Waters Corp
WAT
$38.9B
$3.34M 0.81%
13,500
BIIB icon
36
Biogen
BIIB
$30.8B
$3.1M 0.75%
12,650
-5,900
-32% -$1.52M
BRKR icon
37
Bruker
BRKR
$7.66B
$3.07M 0.75%
56,690
SPY icon
38
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$3.05M 0.74%
8,161
-271
-3% -$96.1K
PFE icon
39
Pfizer
PFE
$145B
$2.87M 0.7%
77,976
-275
-0.4% -$10.1K
SCHM icon
40
Schwab US Mid-Cap ETF
SCHM
$15.1B
$2.86M 0.7%
125,937
-1,689
-1% -$35.2K
IAU icon
41
iShares Gold Trust
IAU
$63.3B
$2.86M 0.69%
78,882
+233
+0.3% +$8.34K
KO icon
42
Coca-Cola
KO
$372B
$2.85M 0.69%
52,060
+8,538
+20% +$441K
CL icon
43
Colgate-Palmolive
CL
$73.8B
$2.85M 0.69%
33,300
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.12T
$2.79M 0.68%
9,220
+1,470
+19% +$324K
XOM icon
45
ExxonMobil
XOM
$638B
$2.75M 0.67%
66,664
-415
-0.6% -$15.6K
ADP icon
46
Automatic Data Processing
ADP
$108B
$2.73M 0.66%
15,470
AEGN
47
DELISTED
Aegion Corp
AEGN
$2.61M 0.63%
137,386
+10,333
+8% +$173K
KEYS icon
48
Keysight
KEYS
$58.3B
$2.47M 0.6%
18,679
VAR
49
DELISTED
Varian Medical Systems, Inc.
VAR
$2.45M 0.6%
14,000
MOAT icon
50
VanEck Morningstar Wide Moat ETF
MOAT
$12.1B
$2.33M 0.57%
37,630
+4,715
+14% +$278K

Similar funds

Mengis Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Mengis Capital Management held 166 positions worth $412M, up 13% from $365M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 4.8%. Mengis Capital Management opened 6 new positions and exited 2, leaving the 166-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Mengis Capital Management's largest Q4 2020 buy was General Dynamics: 3,800 shares worth $565K.
  • Mengis Capital Management added most to Verizon in Q4 2020, an estimated $1.51M increase.
  • Mengis Capital Management's biggest Q4 2020 reduction was Biogen, cutting an estimated $1.52M.
  • Mengis Capital Management fully exited Tyson Foods in Q4 2020, selling an estimated $329K.
  • Mengis Capital Management's ten largest holdings make up 37% of its $412M portfolio in Q4 2020.
  • Mengis Capital Management opened 6 new positions and closed 2 in Q4 2020.
  • Mengis Capital Management's portfolio value rose 13% quarter-over-quarter to $412M.

Based on Mengis Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.